Prime Medicine stock price
NASDAQ:PRME · Nasdaq · Healthcare · sector #16Prime Medicine's chart data is dated 2026-10-21. Recorded technical signals: MA aligned. There are 1 published signal records.
Prime Medicine last closed at $3.81 (-2.81%) on 2026-10-21. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is -3.6×. Its overall grade ranks 569 of 727 stocks in Healthcare.
About this company
Prime Medicine last closed at $3.81 (-2.81%) on 2026-10-21. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 569/727
Valuation grade C
Related stocks
- Crispr TherapeuticsCompetitor
- Intellia TherapeuticsCompetitor
- Editas MedicineCompetitor
About Prime Medicine
- What technical signals does Prime Medicine (PRME) have?
- Prime Medicine current technical signals: MA alignment (score 0.58).
- Is Prime Medicine a cup-and-handle pattern?
- No. Prime Medicine has no valid Cup signal right now.
- What published figures are available for Prime Medicine?
- Market cap: $687.75M. Trailing 12 months PER: -3.6×. Latest quarter PBR: 16.96×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about Prime Medicine, or open the plan table on the main site.
Ask Q about Prime Medicine.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.